Union Health Minister J P Nadda today said that a programme would be developed soon to provide free drugs for Hepatitis B.
The minister announced this yesterday at the 27th Annual Conference of the Asian-Pacific Association for the Study of the Liver (APASL).
The five-day event, which began on March 14, was organised by the Asia Pacific Association for Study of Liver and Institute of Liver and Biliary Sciences (ILBS).
The minister spoke about the implementation of the Hepatitis-C programme, and said availability of free drugs against the disease has been finalised and would be launched very soon across the country, according to a ILBS statement.
"A full programme on Hepatitis-B will be soon developed with availability of free drugs against this deadly virus," he said.
The minister also announced free vaccination against Hepatitis B for all health care workers across India.
Nadda also said liver diseases should be given greater significance and will be included in the non-communicable diseases programme in the near future.
One of the major highlights of the conference included treatment options for liver cancer, the second commonest cause of cancer deaths worldwide.
It is also one of the fastest growing cancers and the only viable treatment is liver transplantation, the statement said.
Over 3,000 delegates from more than 50 countries are attending the event.
Disclaimer: No Business Standard Journalist was involved in creation of this content
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
